Skip to search formSkip to main contentSkip to account menu

Anandron

Known as: Aventis Brand of Nilutamide, Hoechst Brand of Nilutamide 
National Institutes of Health

Related topics

Related topics

2 relations
Nilandron

Broader (1)

nilutamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Nonsteroidal selective androgen receptors modulators (SARMs): designer androgens with flexible structures provide clinical promise.
Androgens play an essential role in differentiation and growth of the male reproductive tract, pubertal maturation and… 
1993
1993
Hépatite fulminante mortelle imputable au nilutamide (Anandron).
Nous rapportons le premier cas d'atteinte hepatique fulminante mortelle imputable a la prise de nilutamide, un anti-androgene… 
1991
1991
Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study.
Between March 1986 and March 1987, 48 patients with stage D prostate carcinoma were entered into a multicentric pilot study using… 
1990
1990
Changes in testis, epididymis and other accessory organs of male rats treated with anandron during sexual maturation.
Anandron (5,5-dimethyl-(4-nitro-3(trifluoromethyl)phenyl)-2,4-imidazolidine-dione ), a nonsteroidal antiandrogen was administered… 
1989
1989
[Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study].
In the course of a randomized double blind trial conducted by 7 Swiss urological centres, 51 patients with advanced, not… 
1988
1988
Anandron (RU 23908) Associated with Orchiectomy in Stage D Prostate Cancer Preliminary Results of a Randomized, Double‐Blind Study
A randomized, double-blind, multicenter trial was performed comparing the association of orchiectomy plus the nonsteroid… 
1988
1988
Efficacy and advantages in the use of low doses of anandron and estrogen combination in the treatment of prostate cancer
Treatment effects of RU 23908 antiandrogen (Anandron®) and estrogen in low doses on hormone‐dependent rat prostatic… 
1987
1987
Towards the mapping of the progesterone and androgen receptors.
Review
1987
Review
1987
Design of antiandrogens and their mechanisms of action: a case study (anandron).
The design of a new drug is conditioned by knowledge of the biochemical mechanisms involved in the etiology of the disease to be… 
1987
1987
Ocular toxicity of anandron.
SIR, In studies previously published in 1983 and 1984 on treatment of prostate cancer with the combination of castration and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)